Dengue: a continuing global threat
Open accessThe DOI matches its Crossref record; 129 of the 130 references it cites were found in a registry or an index.
Abstract
Dengue fever and dengue haemorrhagic fever are important arthropod-borne viral diseases. Each year, there are ∼50 million dengue infections and ∼500,000 individuals are hospitalized with dengue haemorrhagic fever, mainly in Southeast Asia, the Pacific and the Americas. Illness is produced by any of the four dengue virus serotypes. A global strategy aimed at increasing the capacity for surveillance and outbreak response, changing behaviours and reducing the disease burden using integrated vector management in conjunction with early and accurate diagnosis has been advocated. Antiviral drugs and vaccines that are currently under development could also make an important contribution to dengue control in the future.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Until recent advances in vaccine development [16–17], and the approval and potential availability of the first product in 2016 [18], dengue has been unique among the major vector-borne diseases, in that prevention from infection could only be attempted by reducing or eliminating bites by infected vector mosquitoes [19, 20].”
From Is Dengue Vector Control Deficient in Effectiveness or Evidence?: Systematic Review and Meta-analysis (2016) · cites this paper as [20]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Although a vaccine could be available as early as 2016, vector control remains the primary approach used to prevent dengue, the most common and widespread arbovirus of humans worldwide.”
From Is Dengue Vector Control Deficient in Effectiveness or Evidence?: Systematic Review and Meta-analysis (2016) · cites this paper as [20]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dengue and Dengue Hemorrhagic Fever
Gubler, D. J. (1998) · Clinical Microbiology Reviews · doi:10.1128/cmr.11.3.480 · Cited by 4,310
Self-citationLanciotti, R. S., Calisher, C. H., Gubler, D. J., Chang, G. J., & Vorndam, A. V. (1992) · Journal of Clinical Microbiology · doi:10.1128/jcm.30.3.545-551.1992 · Cited by 1,818 · cited 1×
“The most E u r op e P M C F und e r s A u t ho r M a nu s c r i p t s E u r op e P M C F und e r s A u t ho r M a nu s c r i p t s commonly used NAATs are based on a single RT-PCR assay 95,96 , a nested RT-PCR assay 96 or a one-step multiplex RT-PCR assay 97 .”
MethodSelf-citationDengue Viremia Titer, Antibody Response Pattern, and Virus Serotype Correlate with Disease Severity
Vaughn, D. W., Green, S., Kalayanarooj, S., Innis, B. L., Nimmannitya, S., Suntayakorn, S., Endy, T. P., Raengsakulrach, B., Rothman, A. L., Ennis, F. A., et al. (2000) · The Journal of Infectious Diseases · doi:10.1086/315215 · Cited by 1,632 · cited 1×
“One advantage of this assay is the ability to determine viral titre early in dengue illness, which is believed to be an important predictor of disease severity 102 .”
BackgroundGuzmán, M. G., & Kouri, G. (2002) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(01)00171-2 · Cited by 1,163
Spectrum of Disease and Relation to Place of Exposure among Ill Returned Travelers
Freedman, D. O., Weld, L. H., Kozarsky, P. E., Fisk, T., Robins, R., von Sonnenburg, F., Keystone, J. S., Pandey, P., & Cetron, M. S. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa051331 · Cited by 1,081
Dengue and dengue haemorrhagic fever
Rigau-Pérez, J. G., Clark, G. G., Gubler, D. J., Reiter, P., Sanders, E. J., & Vance Vorndam, A. (1998) · The Lancet · doi:10.1016/s0140-6736(97)12483-7 · Cited by 1,051
Self-citationCross-Reacting Antibodies Enhance Dengue Virus Infection in Humans
Dejnirattisai, W., Jumnainsong, A., Onsirisakul, N., Fitton, P., Vasanawathana, S., Limpitikul, W., Puttikhunt, C., Edwards, C., Duangchinda, T., Supasa, S., et al. (2010) · Science · doi:10.1126/science.1185181 · Cited by 943 · cited 1×
“The available data suggest that neutralizing antibodies are the major contributors to protective immunity 124,125 , however the role of the cellular immune response requires further study 123 .”
BackgroundCalisher, C. H., Karabatsos, N., Dalrymple, J. M., Shope, R. E., Porterfield, J. S., Westaway, E. G., & Brandt, W. E. (1989) · Journal of General Virology · doi:10.1099/0022-1317-70-1-37 · Cited by 893 · cited 1×
“These tests are mainly for research and vaccine studies 90–94 .”
BackgroundOriginal antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever
Mongkolsapaya, J., Dejnirattisai, W., Xu, X.-N., Vasanawathana, S., Tangthawornchaikul, N., Chairunsri, A., Sawasdivorn, S., Duangchinda, T., Dong, T., Rowland-Jones, S., et al. (2003) · Nature Medicine · doi:10.1038/nm887 · Cited by 821 · cited 1×
“…CD4 + and CD8 + cells that have a diminished capacity to kill but nonetheless release inflammatory cytokines that contribute to disease severity 51 ; that severe disease is caused by DENVs of increased virulence 52 ; and the suggestion that cross-reactivity between NS1 and human platelets and…”
BackgroundDengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody
Halstead, S., & O'Rourke, E. (1977) · The Journal of Experimental Medicine · doi:10.1084/jem.146.1.201 · Cited by 804 · cited 5×
“Both in vitro and in vivo , macrophages and monocytes participate in antibody-dependent enhancement (ADE) 18–20 .”
BackgroundInfluentialSelf-citation
Research works printed but not linked: 3
- Vorndam, V. & Kuno, G. In Dengue and Dengue Hemorrhagic Fever (eds Gubler, D. J. & Kuno, G.) 313–333 (CAB International, New York, USA, 1997).
- Gubler, D. J. Serologic diagnosis of dengue/dengue haemorrhagic fever. Dengue Bull. 20, 20–23 (1996).
- Singh, K. R. P. & Paul, S. D. Multiplication of arboviruses in cell lines from Aedes albopictus and Aedes aegypti. Curr. Sci. 37, 65–67 (1968).
Cited by
Items 601–700 of 1,001
Nunes, M. R. T., de Souza, W. M., Savji, N., de Figueiredo, M. L. G., Cardoso, J. F., da Silva, S. P., de Lima, C. P. S., Vasconcelos, H. B., Rodrigues, S. G., Lipkin, W. I., et al. (2018) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2018.11.020 · Cited by 33
Drug repositioning for dengue haemorrhagic fever by integrating multiple omics analyses
Amemiya, T., Gromiha, M. M., Horimoto, K., & Fukui, K. (2019) · Scientific Reports · doi:10.1038/s41598-018-36636-1 · Cited by 35
Buensuceso, C. E., Tiu, B. D. B., Lee, L. P., Sabido, P. M. G., Nuesca, G. M., Caldona, E. B., del Mundo, F. R., & Advíncula, R. C. (2021) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-021-03757-y · Cited by 33
“Other than these, serological tests have cross-reactivities with other flaviviruses causing false positives [1].”
BackgroundMethodInfluentialAll-Serotype Dengue Virus Detection through Multilayered Origami-Based Paper/Polymer Microfluidics
Biswas, P., Sulochana, G. N. M., Banuprasad, T. N., Goyal, P., Modak, D., Ghosh, A. K., & Chakraborty, S. K. (2022) · ACS Sensors · doi:10.1021/acssensors.2c01525 · Cited by 33
Elanga-Ndille, E., Dubot‐Pérès, A., Doucouré, S., Mouchet, F., Cornélie, S., Sidavong, B., Fournet, F., & Remoué, F. (2014) · Tropical Medicine & International Health · doi:10.1111/tmi.12280 · Cited by 33
“Almost half of the world’s population is now at risk of infection, especially in urban areas of developing countries (Guzman et al. 2010).”
BackgroundZhou, G., Weng, Z., Shao, X., Liu, F., Nie, X., Liu, J., Wang, D., Wang, C., & Guo, K. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.10.071 · Cited by 33
High rate of unrecognized dengue virus infection in parts of the rainforest region of Nigeria
Onoja, A. B., Adeniji, J. A., & Olaleye, O. D. (2016) · Acta Tropica · doi:10.1016/j.actatropica.2016.04.007 · Cited by 35
Bostan, N., Javed, S., Nabgha-e-Amen, Eqani, S. A. M. A. S., Tahir, F., & Bokhari, H. (2016) · Reviews in Medical Virology · doi:10.1002/rmv.1899 · Cited by 36
Challenges in dengue research: A computational perspective
Lourenço, J., Tennant, W. S. D., Faria, N. R., Walker, A., Gupta, S., & Recker, M. (2017) · Evolutionary Applications · doi:10.1111/eva.12554 · Cited by 34
“Together with the widespread presence of Ae. aegypti and Ae. albopictus , this would indicate that the burden of dengue in Africa is likely to be worse than previously acknowledged (Guzman et al., 2010; Jaenisch et al., 2014; Kyle & Harris, 2008).”
BackgroundMolecular characterization of dengue viruses isolated from patients in Central Java, Indonesia
Kusmintarsih, E. S., Hayati, R., Turnip, O. N., Yohan, B., Suryaningsih, S., Pratiknyo, H., Denis, D., & Sasmono, R. T. (2017) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2017.09.019 · Cited by 33
Shinohara, Y., Konno, A., Nitta, K., Matsuzaki, Y., Yasui, H., Suwa, J., Hiromura, K., & Hirai, H. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1366-4 · Cited by 38
Comparison of stochastic and deterministic frameworks in dengue modelling
Champagne, C., & Cazelles, B. (2019) · Mathematical Biosciences · doi:10.1016/j.mbs.2019.01.010 · Cited by 36
Lima‐Camara, T. N. (2024) · Revista Brasileira de Epidemiologia · doi:10.1590/1980-549720240048 · Cited by 32
“In another laboratory study, it was demonstrated that a 2°C increase in temperature could reduce the EIP for both DENV-2 and DENV-4 serotypes in Aedes aegypti females 37 .”
BackgroundInfluentialTotal Economic Cost and Burden of Dengue in Nicaragua: 1996–2010
Wettstein, Z. S., Fleming, M., Chang, A. Y., Copenhaver, D. J., Wateska, A. R., Bartsch, S. M., Lee, B. Y., & Kulkarni, R. P. (2012) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2012.12-0146 · Cited by 32
“by the Aedes aegypti mosquito vector and is considered the most important arthropod-borne viral infection in humans.(1,2) Worldwide, over 2.”
BackgroundThe importance of hematopoietic progenitor cells in dengue
Tsai, J., Liu, L., Chang, K., Wang, S., Hsiao, H., Clark, K. B., & Perng, G. (2011) · Therapeutic Advances in Hematology · doi:10.1177/2040620711417660 · Cited by 32
“…limited to the tropical and/or subtropical regions of the globe, but recently, due to factors such as the increased frequency of human migration, unplanned urban development, and ineffective vector control, the disease has penetrated into almost every corner of the planet [Guzman et al. 2010].”
BackgroundRojas, D. P., Barrera-Fuentes, G. A., Pavía‐Ruz, N., Salgado-Rodriguez, M., Che‐Mendoza, A., Manrique-Saide, P. C., Vazquez‐Prokopec, G. M., Halloran, M. E., Longini, I. M., & Gómez‐Dantés, H. (2018) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0006847 · Cited by 32
“Currently there is no specific treatment for dengue infection or clinical predictors to prevent severe disease [10].”
BackgroundInfluentialChoo, J. J. Y., Vet, L. J., McMillan, C. L. D., Harrison, J. J., Scott, C. A. P., Depelsenaire, A. C. I., Fernando, G. J. P., Watterson, D., Hall, R. A., Young, P. R., et al. (2021) · npj Vaccines · doi:10.1038/s41541-021-00328-1 · Cited by 32
Paper-based point-of-care testing for diagnosis of dengue infections
Choi, J. R., Hu, J., Wang, S., Yang, H., Abas, W. A. B. W., Pingguan‐Murphy, B., & Xu, F. (2016) · Critical Reviews in Biotechnology · doi:10.3109/07388551.2016.1139541 · Cited by 32
“With the conserved capture probe, a single generic biosensor is capable to detect all four serotype of DENV.”
BackgroundInfluentialVasantha‐Srinivasan, P., Thanigaivel, A., Edwin, E., Ponsankar, A., Senthil‐Nathan, S., Selin‐Rani, S., Kalaivani, K., Hunter, W. B., Duraipandiyan, V., & Al-Dhabi, N. A. (2017) · Environmental Science and Pollution Research · doi:10.1007/s11356-017-9714-x · Cited by 36
“…South Rock Road, Fort Pierce, FL 34945, USA 4 Addiriyah Research Chair for Environmental Studies, Department of Botany andMicrobiology, College of Science, King Saud University, P. O. Box 2455, Riyadh 11451, Saudi Arabia areas in Asia, the Pacific, and the Americas (WHO 2009; Guzman et al. 2010).”
BackgroundPrediction of dengue outbreaks in Mexico based on entomological, meteorological and demographic data
Sánchez‐González, G., Condé, R., Moreno, R. N., & Vázquez, P. C. L. (2018) · PLoS ONE · doi:10.1371/journal.pone.0196047 · Cited by 33
Islam, S., Khan, M. A. S., Badal, M. F. A., Khan, M. Z. I., Gozal, D., & Hasan, M. J. (2022) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0010847 · Cited by 31
“[1] Approximately 100 million dengue infections are estimated to occur annually, with almost 10,000 deaths being reported in 125 countries worldwide.”
BackgroundCosta, V. V., Fagundes, C. T., Valadão, D. F., Ávila, T. V., Cisalpino, D., Rocha, R. D. P. F., Ribeiro, L. S., Ascenção, F. R., Kangussu, L. M., Celso, M. Q., et al. (2014) · Medical Microbiology and Immunology · doi:10.1007/s00430-014-0334-5 · Cited by 31
Cruz, D. J. M., Koishi, A. C., Taniguchi, J. B., Li, X., Bonotto, R. M., No, J. H., Kim, K. H., Baek, S., Kim, H. Y., Windisch, M. P., et al. (2013) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0002073 · Cited by 31
“Coincidentally, the geographical distribution of the four serotypes has also expanded, with all serotypes reported to co-circulate in most of the dengue-endemic countries [7].”
BackgroundCalvez, E., Guillaumot, L., Girault, D., de Soultrait, V. R., O’Connor, O., Paoaafaite, T., Teurlai, M., Pocquet, N., Cao‐Lormeau, V., & Dupont‐Rouzeyrol, M. (2017) · Parasites & Vectors · doi:10.1186/s13071-017-2319-x · Cited by 31
“and targeted vector control strategies in the region to prevent expansion of outbreaks [49, 50].”
BackgroundEmerging and re-emerging infectious diseases in Iran.
Parhizgari, N., Gouya, M. M., & Mostafavi, E. (2017) · PubMed Central · Cited by 36
Grunnill, M. D. (2017) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2017.12.009 · Cited by 34
Carro, A. C., Piccini, L. E., & Damonte, E. B. (2018) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0006685 · Cited by 31
An economic investigation of the dengue incidence as a result of a tailings dam accident in Brazil
Nishijima, M., & Rocha, F. (2019) · Journal of Environmental Management · doi:10.1016/j.jenvman.2019.109748 · Cited by 37
Lai, S.-C., Huang, Y.-Y., Wey, J., Tsai, M.-H., Chen, Y., Shu, P., Chang, S., Hung, Y., Hou, J.-N., & Lin, C.-C. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.852452 · Cited by 31
“Cross-reactive antibodies or subneutralizing concentrations of antibodies binding to heteroserotype dengue virus increase the risk of severe dengue disease (17, 18, 26).”
BackgroundLam, S. K., Burke, D. S., Capeding, M. R., Chong, C. K., Coudeville, L., Farrar, J., Gubler, D. J., Hadinegoro, S. R., Hanna, J. N., Lang, J., et al. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.08.047 · Cited by 31
Self-citationIn search of flavivirus inhibitors: Evaluation of different tritylated nucleoside analogues
Chatelain, G., Debing, Y., Burghgraeve, T. D., Żmurko, J., Saudi, M., Rozenski, J., Neyts, J. H., & Aerschot, A. A. V. (2013) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2013.04.034 · Cited by 31
“Half a million people develop dengue haemorrhagic fever annually, of which ~ 25,000 of these cases are fatal [5].”
BackgroundChang, T.-H., Chen, S.-R., Yu, C.-Y., Lin, Y.-S., Chen, Y.-S., Kubota, T., Matsuoka, M., & Lin, Y. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041635 · Cited by 31
“Several tetravalent DENV vaccine candidates are under development, but an effective, safe and affordable dengue vaccine remains elusive [3].”
BackgroundInfluence of mosquito genotype on transcriptional response to dengue virus infection
Behura, S. K., Gomez-Machorro, C., deBruyn, B. S., Lovin, D. D., Harker, B. W., Romero-Severson, J., Mori, A., & Severson, D. W. (2014) · Functional & Integrative Genomics · doi:10.1007/s10142-014-0376-1 · Cited by 36
“It is well known that different laboratory strains and field isolates of A. aegypti show variable susceptibility to DENV infection, as well as variability in response to different DENV isolates (reviewed in Guzman et al. 2010; Rico-Hesse 2007).”
BackgroundNon-HLA gene polymorphisms and their implications on dengue virus infection
Harapan, H., Fajar, J. K., Wahyuniati, N., Anand, J. R., Nambaru, L., & Jamil, K. F. (2012) · Egyptian Journal of Medical Human Genetics · doi:10.1016/j.ejmhg.2012.08.003 · Cited by 32
“It is estimated that 50 million dengue infections occur annually worldwide [1] and it has increased dramatically in recent years [2].”
BackgroundNew development in the diagnosis of dengue infections
Rathakrishnan, A., & Sekaran, S. D. (2012) · Expert Opinion on Medical Diagnostics · doi:10.1517/17530059.2012.718759 · Cited by 39
“In areas where different serotypes of dengue co-exist and multiple infections occur, lifelong complications arise in the serological diagnosis of this disease, due to pre-existing antibodies, and lower affinity of these antibodies against the second infecting serotype [10].”
BackgroundMethodInfluentialThe effects of mosquito saliva on dengue virus infectivity in humans
Wichit, S., Ferraris, P., Choumet, V., & Missé, D. (2016) · Current Opinion in Virology · doi:10.1016/j.coviro.2016.10.001 · Cited by 36
“Epidemics with a high frequency of DHF/DSS continue to expand geographically in Asia and South America, highlighting the need to control the spread of this disease [2].”
BackgroundChanthick, C., Suttitheptumrong, A., Rawarak, N., & Pattanakitsakul, S. (2018) · Viruses · doi:10.3390/v10020069 · Cited by 31
“It has been suggested that CD4+ and CD8+ T lymphocytes are activated by infected monocytes/macrophages and dendritic cells, which results in increased production of many cytokines and chemokines [15].”
BackgroundMichels, M., de Mast, Q., Netea, M. G., Joosten, L. A. B., Dinarello, C. A., RUDIMAN, P. I. F., Sinarta, S., Wisaksana, R., Alisjahbana, B., & van der Ven, A. J. A. M. (2015) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00147-15 · Cited by 31
“A subset of patients, however, develops life-threatening complications, which include plasma leakage, bleeding, and/or severe organ failure (2, 3).”
BackgroundDengue Virus Infection of Primary Human Smooth Muscle Cells
Arias-Arias, J. L., Vega-Aguilar, F., Corrales‐Aguilar, E., Hun, L., Loria, G. D., & Mora-Rodríguez, R. A. (2018) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.18-0175 · Cited by 30
“The virion comprises an enveloped spherical particle that harbors a positive single-stranded RNA genome.(2) Dengue virus is transmitted by mosquito vectors, mainly Aedes aegypti, and is considered the most important arthropod-borne viral disease worldwide.”
BackgroundScott, V. K., Pinheiro, M. S. N., Machado, M. M. T., & Castro, M. C. (2023) · BMC Public Health · doi:10.1186/s12889-023-17005-8 · Cited by 35
“Becoming infected with a new serotype of dengue after an initial infection is a major risk factor for developing severe dengue [11].”
BackgroundDynamic Spatiotemporal Trends of Dengue Transmission in the Asia-Pacific Region, 1955–2004
Banu, S., Hu, W., Guo, Y., Naish, S., & Tong, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089440 · Cited by 35
“Historically, the first severe DF outbreak occurred in Manila (Philippines) in 1953, and the second outbreak was in Bangkok (Thailand) [24,37].”
BackgroundCamargo, F. D. A., Adimy, M., Esteva, L., Métayer, C., & Ferreira, C. P. (2021) · Bulletin of Mathematical Biology · doi:10.1007/s11538-021-00919-y · Cited by 37
Demarque, D. P., & Espíndola, L. S. (2021) · Frontiers in Chemistry · doi:10.3389/fchem.2021.779049 · Cited by 31
“The most prevalent in South America is dengue, which has been reported since the 1980s (Guzman et al., 2010).”
BackgroundDang, M., Lim, L., Roy, A., & Song, J. (2022) · ACS Omega · doi:10.1021/acsomega.1c05569 · Cited by 30
Temporal trend and spatial clustering of the dengue fever prevalence in West Java, Indonesia
Fauzi, I. S., Nuraini, N., Ayu, R. W. S., & Lestari, B. W. (2022) · Heliyon · doi:10.1016/j.heliyon.2022.e10350 · Cited by 36
Dengue virus and its recent outbreaks: current scenario and counteracting strategies
Sah, R., Siddiq, A., Padhi, B. K., Mohanty, A., Rabaan, A. A., Chandran, D., Chakraborty, C., & Dhama, K. (2023) · International Journal of Surgery · doi:10.1097/js9.0000000000000045 · Cited by 30
“and relatively available compared to other techniques of viral isolation or nucleic acid detection([18]).”
BackgroundPredictive Value of Proteinuria in Adult Dengue Severity
Vasanwala, F. F., Thein, T.-L., Leo, Y., Gan, V. C. H., Ying, H., Lee, L. K., & Lye, D. C. (2014) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0002712 · Cited by 37
Ambuel, Y., Young, G. R., Brewoo, J. N., Paykel, J., Weisgrau, K. L., Rakasz, E. G., Haller, A. A., Royals, M. A., Huang, C. Y. ‐., Capuano, S., et al. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00263 · Cited by 30
Huang, J., Li, Y., Qi, Y., Zhang, Y., Zhang, L., Wang, Z., Zhang, X., & Gui, L. (2014) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-014-2183-3 · Cited by 32
Douglas, D., DeRoeck, D., Mahoney, R. T., & Wichmann, O. (2013) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0002127 · Cited by 29
“systems [1,2].”
Public Health Responses to a Dengue Outbreak in a Fragile State: A Case Study of Nepal
Griffiths, K., Banjara, M. R., O’Dempsey, T., Munslow, B., & Kroeger, A. (2013) · Journal of Tropical Medicine · doi:10.1155/2013/158462 · Cited by 32
Self-citationNobori, H., Toba, S., Yoshida, R., Hall, W. W., Orba, Y., Sawa, H., & Sato, A. (2018) · Antiviral Research · doi:10.1016/j.antiviral.2018.05.003 · Cited by 29
Lim, L., Gupta, G., Roy, A., Kang, J., Srivastava, S., Shi, J., & Song, J. (2018) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2018.08.009 · Cited by 29
“The disease is caused by Dengue virus (DENV) of the Flaviviridae family, which also includes several other human pathogens including the West Nile virus, Japanese encephalitis virus, yellow fever virus and Zika virus (Bhatt et al., 2013; Guzman et al., 2010; Chan et al., 2016a,b; Ramos da Silva and Gao, 2016; Dick et…”
Kühl, N., Leuthold, M. M., Behnam, M. A. M., & Klein, C. D. P. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c02042 · Cited by 29
Highly sensitive detection of dengue biomarker using streptavidin-conjugated quantum dots
Tran, L., & Park, S. (2021) · Scientific Reports · doi:10.1038/s41598-021-94172-x · Cited by 29
Alagarasu, K., Bachal, R. V., Memane, R. S., Shah, P. S., & Cecilia, D. (2014) · Immunobiology · doi:10.1016/j.imbio.2014.09.020 · Cited by 29
Hall‐Mendelin, S., Allcock, R. J. N., Kresoje, N., van den Hurk, A. F., & Warrilow, D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058026 · Cited by 29
“These viruses can cause large epidemics [1,2,3] and, as they are arthropod-borne, are commonly referred to as arboviruses.”
BackgroundDual miRNA Targeting Restricts Host Range and Attenuates Neurovirulence of Flaviviruses
Tsetsarkin, K. A., Liu, G., Kenney, H., Bustos‐Arriaga, J., Hanson, C. T., Whitehead, S. S., & Pletnev, A. G. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1004852 · Cited by 32
“However, reduction of funding allocated to mosquito control campaigns during the last decades, accompanied by an increase in human population density and global travel [1,2] resulted in an increase in the number of flavivirus-associated illnesses [1–3].”
BackgroundBehura, S. K., & Severson, D. W. (2013) · BMC Microbiology · doi:10.1186/1471-2180-13-37 · Cited by 31
“Disease severity of dengue is often attributed to secondary infection with a virus belonging to a serotype other than that of the primary infection, but evolution of the virus is also considered as a significant contributing factor to increased epidemics of dengue [4].”
BackgroundYe, Y. H., Ng, T. S., Frentiu, F. D., Walker, T., van den Hurk, A. F., O’Neill, S. L., Beebe, N. W., & McGraw, E. A. (2014) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.13-0186 · Cited by 30
Galula, J. U., Shen, W.-F., Chuang, S.-T., Chang, G. J., & Chao, D. (2014) · Journal of Virology · doi:10.1128/jvi.00810-14 · Cited by 29
Decay and Persistence of Maternal Dengue Antibodies among Infants in Bangkok
van Panhuis, W. G., Luxemburger, C., Pengsaa, K., Limkittikul, K., Sabchareon, A., Lang, J., Durbin, A. P., & Cummings, D. A. T. (2011) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2011.11-0125 · Cited by 29
FACTORS PREDICTING MORBIDITY IN PATIENTS WITH DENGUE FEVER IN A TERTIARY CARE HOSPITAL
Khan, M. I., Anwar, E., Agha, A., Saleh, N., Ullah, E., Syed, I. A., & Raja, A. J. (2013) · Mediterranean Journal of Hematology and Infectious Diseases · doi:10.4084/mjhid.2013.014 · Cited by 29
“Citation: Mediterr J Hematol Infect Dis 2013, 5(1): e2013014, DOI: 10.”
BackgroundRao, M. R. K., Padhy, R. N., & Das, M. K. (2017) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2017.12.005 · Cited by 29
Carneiro, A. R., Cruz, A. C. R., Vallinoto, M., Melo, D. D. V., Ramos, R. T. J., Medeiros, D. B. D. A., da Silva, E. V. P., & Vasconcelos, P. F. D. C. (2012) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/s0074-02762012000600016 · Cited by 28
“This analysis also showed that different introductions of strains from the 1990s represented lineage replacement, with the identification of three lineages that cluster all isolates from the Americas.”
BackgroundInfluentialMedusa: A Novel Gene Drive System for Confined Suppression of Insect Populations
Marshall, J. M., & Hay, B. A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0102694 · Cited by 32
“For dengue fever, there are currently no drugs or vaccines available and so control measures are limited to suppression of the vector species Aedes aegypti [6].”
BackgroundAssessment of Dengue fever severity through liver function tests.
Ahmed, A., Alvi, A., Butt, A., Nawaz, A. A., & Hanif, A. (2014) · PubMed · Cited by 28
Dengue serotype circulation in natural populations of Aedes aegypti
dos Santos, T. P., Cruz, O. G., da Silva, K. A. B., de Castro, M. G., Brito, A., Maspero, R., de Alcântra, R., dos Santos, F. B., Honório, N. A., & Lourenço‐de‐Oliveira, R. (2017) · Acta Tropica · doi:10.1016/j.actatropica.2017.07.014 · Cited by 29
Pang, E. L., Peyret, H., Ramirez, A., Loh, H., Lai, K., Fang, C.-M., Rosenberg, W. M., & Lomonossoff, G. P. (2019) · Frontiers in Plant Science · doi:10.3389/fpls.2019.00455 · Cited by 28
Lee, J., Kim, J., Shin, H., & Min, D. (2020) · 2D Materials · doi:10.1088/2053-1583/ab9a64 · Cited by 29
Park, G., Park, H., Park, S. C., Jang, M., Yoon, J., Ahn, J., & Lee, T. (2023) · Nanomaterials · doi:10.3390/nano13020361 · Cited by 30
“5 billion people live in DENV-affected areas, with roughly 400 million infections per year, and mortality rates in some areas have been reported to exceed 5–20% [17,18].”
BackgroundInfluentialAminotransferases in Relation to the Severity of Dengue: A Systematic Review
Kalluru, P. K. R., Mamilla, M., Valisekka, S. S., Mandyam, S., Martinez, E. C., Posani, S., Sharma, S., Gopavaram, R. R., Gargi, B., Anvitha, G., et al. (2023) · Cureus · doi:10.7759/cureus.39436 · Cited by 29
“Individuals with this infection have detectable amounts of the NS1 protein in their serum, which is a diagnostic indicator [23].”
BackgroundAmorim, J. H., Bizerra, R. S. P., Alves, R. P. D. S., Sbrogio-Almeida, M. E., Levi, J. E., Capurro, M. L., & Ferreira, L. C. D. S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044984 · Cited by 28
“These results are indicative of the higher immunogenicity of the NS1 protein compared with the E protein and reflect the early synthesis and secretion of the NS1 protein during the infection course [43,63].”
BackgroundResultThioaptamers targeting dengue virus type-2 envelope protein domain III
Gandham, S. H. A., Volk, D. E., Lokesh, G. L.-R., Neerathilingam, M., & Gorenstein, D. G. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.09.053 · Cited by 28
Bacterial larvicides for vector control: mode of action of toxins and implications for resistance
Ferreira, L. M., & Silva‐Filha, M. H. N. L. (2013) · Biocontrol Science and Technology · doi:10.1080/09583157.2013.822472 · Cited by 28
“Diseases transmitted by vectors are under expansion, such as dengue, which is the most important re-emerging arbovirus in tropical and subtropical countries (Guzman et al., 2010; Kyle & Harris, 2008).”
BackgroundMolecular surveillance of Dengue in Sukabumi, West Java province, Indonesia
Nusa, R., Prasetyowati, H., Meutiawati, F., Yohan, B., Trimarsanto, H., Setianingsih, T. Y., & Sasmono, R. T. (2014) · The Journal of Infection in Developing Countries · doi:10.3855/jidc.3959 · Cited by 28
“The genome consists of single-stranded positive-sense RNA, which encodes three structural (C, prM/M, E) and seven non-structural proteins (NS1, NS2A, NS2B, NS3, NS4A, NS4B, NS5) [1].”
BackgroundÁñez, G., Heisey, D. A. R., Espina, L. M., Stramer, S. L., & Rios, M. (2012) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2012.12-0091 · Cited by 28
“influenza-like disease (dengue fever) to a potentially lifethreatening condition known as severe dengue/dengue hemorrhagic fever.(1)”
Space-time scan statistics of 2007-2013 dengue incidence in Cimahi city, Indonesia
Dhewantara, P. W., Ruliansyah, A., Fuadiyah, M. E. A., Astuti, E. P., & Widawati, M. (2015) · Geospatial health · doi:10.4081/gh.2015.373 · Cited by 31
Understanding Dengue Virus Capsid Protein Interaction with Key Biological Targets
Faustino, A. F., Martins, I. C., Carvalho, F. A., Castanho, M. A. R. B., Maurer‐Stroh, S., & Santos, N. C. (2015) · Scientific Reports · doi:10.1038/srep10592 · Cited by 33
Oral manifestations related to dengue fever: a systematic review of the literature
Pedrosa, M., de Paiva, M., Oliveira, L., Pereira, S., da Silva, C., & Pompeu, J. G. F. (2017) · Australian Dental Journal · doi:10.1111/adj.12516 · Cited by 28
“Annually, 100 million cases of classical DH and 500 million cases of dengue haemorrhagic fever (DHF) are reported globally, with an average fatality rate of 5–20%.(9)”
BackgroundTambunan, U. S. F., Nasution, M. A. F., Azhima, F., Parikesit, A. A., Toepak, E. P., Idrus, S., & Kerami, D. (2017) · Drug Target Insights · doi:10.1177/1177392817701726 · Cited by 30
Mirza, S. B., Lee, R. C. H., Chu, J. J. H., Salmas, R. E., Mavromoustakos, T., & Durdağı, S. (2017) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2017.10.010 · Cited by 28
Tsai, J., Liu, L., Lin, P., Tsai, C., Chou, P.-H., Tsai, Y., Chang, H. G., & Lee, P.-Y. A. (2018) · Journal of Clinical Microbiology · doi:10.1128/jcm.01865-17 · Cited by 28
Tchuandom, S. B., Tchouangueu, T. F., Antonio‐Nkondjio, C., Lissom, A., Djang, J. O. N., Atabonkeng, E. P., Kechia, A., Nchinda, G., & Kuiate, J. (2018) · Pan African Medical Journal · doi:10.11604/pamj.2018.31.177.16390 · Cited by 28
“Dengue in tropical and subtropical regions has increased due to uncontrolled urbanization, lack of effective and sustainable vector control programs [38].”
BackgroundWilson, J. J., Harimuralikrishnaa, T., Sivakumar, T., Mahendran, S., Ponmanickam, P., Thangaraj, R., Sevarkodiyone, S., Alharbi, N. S. H. A., Kadaikunnan, S., Venkidasamy, B., et al. (2023) · Bioengineering · doi:10.3390/bioengineering10020248 · Cited by 27
Kim, S., Yang, I.-Y., Jang, S., Kim, J., Truong, T. T., Pham, T. V., Truong, N. U., Lee, K., & Jang, Y. (2013) · Microbes and Infection · doi:10.1016/j.micinf.2013.07.006 · Cited by 30
Msellemu, D. F., Gavana, T., Ngonyani, H., Mlacha, Y. P., Chaki, P., & Moore, S. (2020) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0007278 · Cited by 28
“…change communication messages to 1) improve household level environmental modification or destruction of breeding sites around homes, 2) to encourage adherence to personal protection and 3) identification of disease symptoms of the disease as is successfully used in many endemic countries [25].”
O’Connor, O., Ou, T. P., Aubry, F., Dabo, S., Russet, S., Girault, D., In, S., Minier, M., Lequime, S., Hoem, T., et al. (2021) · Emerging Microbes & Infections · doi:10.1080/22221751.2021.1944789 · Cited by 27
“Four genetically distinct serotypes (DENV-1 to -4), sharing approximately 65% amino acid identity, can be distinguished [3].”
BackgroundHypocalcemia is associated with disease severity in patients with dengue
Constantine, G. R., Rajapakse, S., Ranasinghe, P. D., Parththipan, B., Wijewickrama, A., & Jayawardana, P. (2014) · The Journal of Infection in Developing Countries · doi:10.3855/jidc.4974 · Cited by 27
“Each year, there are ∼50 million dengue infections and ∼500,000 individuals are hospitalized with DHF, mainly in Southeast Asia, the Pacific, and the Americas [18].”
BackgroundThreats from emerging and re-emerging neglected tropical diseases (NTDs)
Mackey, T. K., & Liang, B. A. (2012) · Infection Ecology & Epidemiology · doi:10.3402/iee.v2i0.18667 · Cited by 27
Limonta, D., Falcón, V., Torres, G., Capó, V. A., Menéndez, I., Rosario, D., Castellanos, Y., Alvarez, M., Rodríguez, R., de la Rosa, M. C., et al. (2012) · Infection · doi:10.1007/s15010-012-0260-7 · Cited by 27
Carvalho, D. M., Garcia, F. G., Terra, A. P. S., Tosta, A. C. L., Teixeira, L. D. A. S., Castellano, L. R. C., & Teixeira, D. N. S. (2014) · Journal of Tropical Medicine · doi:10.1155/2014/901276 · Cited by 27
“5 billion people are at high risk, living in dengue endemic areas [1–3].”
BackgroundGenetic polymorphisms of molecules involved in host immune response to dengue virus infection
Fang, X. D., Hu, Z., Shang, W., Zhu, J., Xu, C., & Rao, X. (2012) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2012.00995.x · Cited by 27
Dengue Virus Serotype 2 (DEN-2): the Causative Agent of 2011-Dengue Epidemic in Pakistan
Idrees, M., Hussain, W., Rehman, H. U., Tayyab, G. U. N., Afzal, S., Fatima, Z., Akram, M., Raza, S. M., Ali, L., Hussain, A., et al. (2012) · American Journal of Biomedical Sciences · doi:10.5099/aj120400307 · Cited by 27
“313 virus infection that pose a continous global threat to human health (11).”
BackgroundIncidence of dengue in 2013: Dengue outbreak in District Swat, Khyber Pakhtunkhwa, Pakistan
Khan, J., & Khan, A. (2015) · International Journal of Fauna and Biological Studies · Cited by 27
A systematic review of the economic impact of rapid diagnostic tests for dengue
Lim, J. K., Alexander, N. D. E., & Tanna, G. L. D. (2017) · BMC Health Services Research · doi:10.1186/s12913-017-2789-8 · Cited by 30
“One test routinely used by research laboratories for virus identification is Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR) assay [32].”
MethodSedda, L., Vilela, A. P. P., Aguiar, E. R. G. R., Gaspar, C. H. P., Gonçalves, A. N. A., Olmo, R. P., Silva, A. T. S., da Silveira, L. D. C., Eiras, Á. E., Drumond, B. P., et al. (2018) · Parasites & Vectors · doi:10.1186/s13071-018-2662-6 · Cited by 29
“Indeed, viraemia is detectable for only a short period during the early stages of infection, which usually coincides with the appearance of symptoms [46].”
BackgroundSun, P., Williams, M., Nagabhushana, N., Jani, V., Defang, G. N., & Morrison, B. J. (2019) · Scientific Reports · doi:10.1038/s41598-018-36972-2 · Cited by 27
Luppe, M. J., Verro, A. T., Barbosa, A. S., Nogueira, M. L., Undurraga, E. A., & da Silva, N. S. (2019) · Travel Medicine and Infectious Disease · doi:10.1016/j.tmaid.2019.05.002 · Cited by 28
Áñez, G., Heisey, D. A. R., Volkova, E., & Rios, M. (2016) · Genome Announcements · doi:10.1128/genomea.01583-15 · Cited by 27
“To date, there are no vaccines or specific antiviral treatments for DENV (2).”
Background
Metadata
- Authors
- Guzman, M. G., Halstead, S. B., Artsob, H., Buchy, P., Farrar, J., Gubler, D. J., Hunsperger, E., Kroeger, A., Margolis, H. S., Martínez, E., Nathan, M. B., Pelegrino, J. L., Simmons, C., Yoksan, S., & Peeling, R. W.
- Affiliations
- Public Health Agency of Canada (CA)
- Institut Pasteur du Cambodge (KH)
- Oxford University Clinical Research Unit (VN)
- National University of Singapore (SG)
- Centers for Disease Control and Prevention (US)
- World Bank (US)
- Instituto de Medicina Tropical “Pedro Kourí” (CU)
- World Health Organization (CH)
- Mahidol University (TH)
- Corresponding author
- Peeling, Rosanna W.
- ORCID
- Venue
- Nature Reviews Microbiology
- Published
- 2010-12
- Volume
- 8
- Issue
- S12
- Pages
- S7-S16
- ISSN
- 1740-1526 (ISSN-L)
- 1740-1534
- PMC
- PMC4333201
- OpenAlex
- W2042479028
- Cited by
- 2,082
- References
- 130
- Citations by year
- 2026: 68 · 2025: 104 · 2024: 94 · 2023: 135 · 2022: 116 · 2021: 133 · 2020: 140 · 2019: 127 · 2018: 142 · 2017: 151 · 2016: 163 · 2015: 189 · 2014: 186 · 2013: 161 · 2012: 132
- FWCI
- 15.35
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Reviews Microbiology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
- Minerva Access (University of Melbourne) (submittedVersion)
- Funders
- Wellcome Trust (084368)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Mosquito-borne diseases and control
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Dengue and Mosquito Control Research
- Health Sciences › Medicine › Infectious Diseases › Viral Infections and Vectors
- Keywords
- dengue, dengue hemorrhagic fever, arboviruses, dengue serotypes, vector-borne diseases, dengue surveillance, outbreak response, integrated vector management, early diagnosis, dengue vaccine, antiviral agents, dengue control
- MeSH terms
- Americas, Asia, Southeastern, Dengue, Dengue Virus, Hospitalization, Humans, Insect Control, Pacific Islands
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.